Back

Prevalence of high inflammatory risk (hsCRP ≥2 mg/L) in European patients with atherosclerotic cardiovascular disease with/without chronic kidney disease: sub-analysis of the global POSEIDON study

31 August 2026 (08:45 - 08:55)
Organised by: Logo
Congress Presentation Part of: Modulation of risk and outcomes in peripheral artery disease Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor David Manuel Leistner

Wolfgang Goethe University, Frankfurt (Germany)

5 More presentations in this session

Presentation thumbnail
Multistate modeling of clinical trajectories and transition-specific risk patterns in peripheral artery disease
Doctor Y. ZHANG (Shatin, HK) Doctor G. Tan (Shatin, HK)
Abstract Slides
Presentation thumbnail
Subcutaneous semaglutide and peripheral arterial occlusive disease in type 2 diabetes: network meta-analysis of randomized trials
Doctor M. Movahed (Tucson, US)
Abstract Slides
Presentation thumbnail
Adherence to statins with risk of cardiovascular and limb events in peripheral artery disease
Doctor M. Ude (Dallas, US)
Abstract Slides
Presentation thumbnail
A novel machine learning derived proteomics-leveraged panel to predict presence and prognosis of obstructive peripheral artery disease: the CASABLANCA Study
Professor J. Januzzi (Boston, US)
Abstract Slides
Presentation thumbnail
Effects of semaglutide on walking distance, symptoms and rescue treatment by baseline medical therapy and LDL cholesterol levels: insights from the STRIDE trial
Doctor M. Bonaca (Aurora, US)
Abstract Slides

Access the full session

Session thumbnail
Modulation of risk and outcomes in peripheral artery disease
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 08:45 CET
You may be interested in
thumbnail
Congress Presentation
High-sensitivity C-Reactive protein predicts post-percutaneous coronary intervention cardiovascular risk with CKD status effect: evidence from a prospective registry study
30 August 2025
thumbnail
Congress Presentation
Treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe: baseline demographics from the multinational observational SANTORINI study
27 August 2021
thumbnail
Congress Presentation
Sex differences in cardiovascular inflammation defined by high-sensitivity C-reactive protein across heart failure phenotypes: insights from POSEIDON
30 August 2026
thumbnail
Congress Presentation
Association of inflammatory markers and ultrasonographic indicators of endothelial (dys)function in humans
12 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources